What We're Reading: Page 113
Industry reads hand-picked by our editors
Oct 07, 2022
Oct 06, 2022
Oct 05, 2022
Oct 04, 2022
-
USA Today
One big change is coming to clinical drug trials, and it’s ‘no longer lip service’
-
Science
‘Cycles of panic and neglect’: Head of Pandemic Prevention Institute explains its early death
-
The Wall Street Journal
World’s Most Expensive Drugs Can’t Cure What Ails This Biotech
-
Endpoints News
FTC chair Lina Khan pledges to use all tools to investigate PBMs
-
BioPharma Dive
5 FDA decisions to watch in the fourth quarter
Oct 03, 2022
-
The New York Times
Nobel Prize in Physiology or Medicine Is Awarded to Svante Pääbo
-
Financial Times
Moderna refused China request to reveal vaccine technology
-
Axios
HHS: Prices of 1,200 drugs rose faster than inflation
-
Evaluate Vantage
FDA scrutiny now hits Parp inhibitors
Sep 30, 2022
-
Reuters
Eisai’s trial success raises hope for Alzheimer’s prevention
-
The New York Times
China Gets Its First mRNA Covid Vaccine Approval — in Indonesia
-
FiercePharma
Intercept’s Ocaliva fails its 2nd NASH trial
Sep 29, 2022
-
The Boston Globe
2 Boston-area scientists win prestigious Lasker Awards for cell research
-
Bloomberg
Global Monkey Shortage for Experiments Boosts China’s Vaccine Development
-
The Wall Street Journal
SK Capital Buys Generic-Drug Firm Founded by Murdered Canadian Billionaire
-
Nature
‘Bionic pancreas’ tames diabetes blood-sugar spikes
Previous
